Dexcom G7 Continuous Glucose Monitoring System— 510(k) K240902

Substantially Equivalent

Dexcom, Inc.

FDA 510(k) clearance K240902 for Dexcom G7 Continuous Glucose Monitoring System, Substantially Equivalent on 2024-04-23. Applicant: Dexcom, Inc.. Device class: 2.

Clearance details

Applicant
Dexcom, Inc.
Product code
Code QBJ
Device class
Class 2
Regulation
21 CFR 862.1355
Advisory panel
Clinical Chemistry
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Special
Location
San Diego, CA, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code QBJ

view all

More clearances from Dexcom, Inc.

view all

Adverse events under product code QBJ

product code QBJ
Death
180
Injury
31,825
Malfunction
1,792,244
Other
36
Total
1,824,285

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Recalls naming K240902

K-number listed on FDA's recall record

Matched by K-number from FDA's Recall Enterprise System record (openFDA device/recallk_numbers) — these recalls explicitly list K240902.

Data sourced from openFDA. This site is unofficial and independent of the FDA.